FICHe eHealth Accelerator Enters Final Phase with 20 Companies

FICHeThe FICHe eHealth accelerator has announced the 20 companies that will enter the third and final phase of the program. The final phase will be a 7-month mentorship period and each company will receive up to € 152.000 in working capital.

Timo Haikonen, chairman of the evaluation committee: "It has been most gratifying to monitor and witness the enthusiasm, innovation and dedication of the FICHe finalists. Every one of them deserves a credit for their hard work. May success follow them all."

Michel van Schaik, member of the evaluation committee adds: "The overall quality of all the participants was very good. Seeing all these innovations brought to the health sector in one place, proofs there is a lot of potential out there."

Paul Pelsmaeker, founder of the European FICHe accelerator: "We are all very excited about the outcome of the evaluation. All twenty selected companies have great potential in the market and that drives the FICHe team and coaches to help them grow in the next 7 months."

The companies selected for the final phase of FICHe are:

  • Px Healthcare (Netherlands), patient experience optimizing oncology outcomes;
  • Panatomy (Germany), online smart imaging database;
  • NeticTECH (Poland), medVC, remote video/audio consultation tool;
  • Medbravo (Spain), finding treatment options based on clinical trial for cancer patients;
  • Clinical Graphics (Netherlands), cloud based service for detection of osteoarthritis;
  • Andiamo (United Kingdom), 3D body scans collaboration cloud platform;
  • Psico Smart Apps (Spain), virtual environments for the treatment of anxiety disorders;
  • Scyfer (Netherlands), deep learning platform to detect degenerative brain disease in 3D-MRI;
  • Betawerk (Netherlands), IncoSense Smart, smart care service that measures incontinence;
  • Tripmedic (Malta), multi-sided platform to match-make international patients to doctors;
  • Mind Myths (Ireland); online mindfulness platform;
  • OurPath (United Kingdom), 12-week online lifestyle programme to prevent T2D;
  • Oviva (Switzerland), remote personal dietitian platform;
  • PLUX (Portugal), biofeedback modules for Ara platform;
  • Inbiolab (Netherlands). hARMONIC, miniaturized respiratory monitor based on EMG;
  • Ideable Solutions (Spain), Kwido, multi-device platform for the care of people;
  • NeuroAtHome (Spain), gamified software platform to deliver physical and cognitive therapy;
  • HealthApp (Spain), mobile application for the treatment of eating disorders;
  • Umanick (Spain), biometric platform for patient identification with HIS/EMR integration;
  • MySphera (Spain), tools to offer full transparency of healthcare processes in hospitals.

The twenty companies will be mentored and coached through an intense 7-month period led by the three ecosystems (Amsterdam, Murcia and Oulu) that are part of the project consortium.

The FICHe accelerator program will conclude with a demo day in 2016 where all companies will present to investors.

Related news articles:

About FICHe
FICHe provides companies with the overall funding of EUR 6.24 million for developing eHealth applications and creating sustainable business models. Funding will be distributed through a three-step process. In the first stage, companies will receive 15 000 euro for business model development. In the next phase, 40 out of the 80 companies will receive 50 000 euro for proof-of-concept. The third phase entering 20 out of the 40 companies will receive additionally 152 000 euro for working prototype development. At best, companies are therefore offered up to 217 000 euros funding.

FICHe is co-funded under the European Union's Programme for research, technological development and demonstration. Project partners are University of Oulu, Business Oulu, TIC BioMed, FFIS de la region de Murcia, TNO, Amsterdam Economic Board, Stichting zorgInc., Dutch eHealth Fund Management BV and Stichting Digitalezorg.nl.

About FIWARE technology
FIWARE is an innovative, open cloud-based infrastructure for cost-effective creation and delivery of Future Internet applications and services, at a scale not seen before. FIWARE API specifications are public and royalty-free, driven by the development of an open source reference implementation which accelerates the availability of commercial products and services based on FIWARE technologies.

Most Popular Now

Elsevier Adds to its Extensive Free Reso…

Elsevier, a global leader in information analytics specializing in science and health, is offering free access to a unique set of biomedical research tools and content to help researchers and...

Cancer Care Model could Help Us Cope wit…

As the UK government looks for an exit strategy to Britain's COVID-19 lockdown a nanomedicine expert from The University of Manchester believes a care model usually applied to cancer patients...

An EU Approach for Efficient Contact Tra…

EU Members States, supported by the Commission, have developed an EU toolbox for the use of mobile applications for contact tracing and warning in response to the coronavirus pandemic. This...

COVID-19 and Health Tech: Building on th…

Highland Marketing's advisory board met to discuss the health tech response to the coronavirus outbreak. In many areas, this has been hugely impressive: but there are gaps, and there will...

New AI Diagnostic can Predict COVID-19 w…

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based...

Biomax Provides AI-Based Semantic Search…

The bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful...

InsurTech Hub Munich and dmac/Digital He…

InsurTech Hub Munich (ITHM) and dmac - Medical Valley Digital Health Application Center part of the Digital Health Hub Nuremberg/Erlangen announce a new cross-industry accelerator for the second half of...

Telemedicine Transforms Response to COVI…

A rapid increase in "virtual" visits during the COVID-19 pandemic could transform the way physicians provide care in the United States going forward, according to a new study led by...

Supercomputer Simulations Present Potent…

Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research...

Viveo Health Offers Free Telemedicine So…

Viveo Health, a global e-Health innovator, is making its 'Virtual Office for Doctors' platform free of charge to doctors and other medical professionals worldwide in light of the surge in...

The Dedalus Group, Participated by Ardia…

The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve...

The COVID-19 pandemic reveals the potent…

Two new articles provide insights on the use of telehealth or virtual care in the age of COVID-19 and beyond, pointing to its value to not only prevent contagious diseases...